Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular approaches toward a therapy for multiple sclerosis.

L Steinman1

  • 1Stanford University School of Medicine, California 94305.

Rivista Di Neurologia
|May 1, 1987
PubMed
Summary

Monoclonal antibody therapy targeting immune response genes and T cells can reverse paralysis and prevent relapses in experimental allergic encephalomyelitis. This approach shows promise for treating multiple sclerosis in humans.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice.

Clinical and experimental immunology·2016
Same author

Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future.

Revue neurologique·2014
Same author

A scientific sequel to Stieg Larsson: relationship between Pandemrix--pandemic influenza vaccine--and the subsequent development of narcolepsy.

Journal of internal medicine·2013
Same author

Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.

Neurology·2012
Same author

Functional rescue of experimental ischemic optic neuropathy with αB-crystallin.

Eye (London, England)·2011
Same author

Inverse vaccination, the opposite of Jenner's concept, for therapy of autoimmunity.

Journal of internal medicine·2010

Area of Science:

  • Immunology
  • Neuroscience
  • Experimental Therapeutics

Background:

  • Experimental allergic encephalomyelitis (EAE) serves as a model for autoimmune neurological diseases.
  • Immune response genes and T cell surface markers play critical roles in the pathogenesis of EAE.

Purpose of the Study:

  • To review the efficacy of monoclonal antibody therapy targeting immune response genes and T cells in EAE.
  • To explore the potential of these therapies for treating human autoimmune neurological conditions, including multiple sclerosis.

Main Methods:

  • Review of studies involving monoclonal antibody treatment in EAE models.
  • Analysis of antibody targets including Ia antigens and T4 surface markers.
  • Examination of therapeutic effects on paralysis and relapse.

Main Results:

  • Anti-Ia and anti-T4 therapies demonstrated the ability to reverse ongoing paralysis in EAE.
  • These therapies were also effective in blocking subsequent relapses of the disease.
  • T4 cells and Ia antigens were observed during relapse phases, indicating their involvement.

Conclusions:

  • Monoclonal antibody therapy targeting specific immune components is a viable strategy for EAE treatment.
  • Chimeric human-mouse immunoglobulins offer potential for human immunotherapy.
  • Further research into these immunotherapies could lead to effective treatments for multiple sclerosis.

Related Experiment Videos